Cargando…
The T-box transcription factor 3 is a promising biomarker and a key regulator of the oncogenic phenotype of a diverse range of sarcoma subtypes
Sarcomas represent a complex group of malignant neoplasms of mesenchymal origin and their heterogeneity poses a serious diagnostic and therapeutic challenge. There is therefore a need to elucidate the molecular mechanisms underpinning the pathogenesis of the more than 70 distinguishable sarcoma subt...
Autores principales: | Willmer, T, Cooper, A, Sims, D, Govender, D, Prince, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154352/ https://www.ncbi.nlm.nih.gov/pubmed/26900951 http://dx.doi.org/10.1038/oncsis.2016.11 |
Ejemplares similares
-
The T-box transcription factor TBX3 drives proliferation by direct repression of the p21(WAF1) cyclin-dependent kinase inhibitor
por: Willmer, Tarryn, et al.
Publicado: (2016) -
Managing sarcoma: where have we come from and where are we going?
por: Bleloch, Jenna S., et al.
Publicado: (2017) -
Prevalence of PD-L1 expression in matched recurrent and/or metastatic sarcoma samples and in a range of selected sarcomas subtypes
por: Vargas, Ana Cristina, et al.
Publicado: (2020) -
Key transcriptional effectors of the pancreatic acinar phenotype and oncogenic transformation
por: Azevedo-Pouly, Ana, et al.
Publicado: (2023) -
The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis
por: Peres, Jade, et al.
Publicado: (2014)